Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | LDHA | P00338 | 1/20 | 0.41 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.41 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.41 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.41 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 9/20 | 0.40 |
| ▸ | CA2 | P00918 | 9/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | CTH | P32929 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1644077 | 1.00 | LMNA (0.41) | LMNALDHASRRALKBH5SUCNR1 | |
| SCHEMBL163217 | 0.97 | LMNA (0.44) | LMNALDHASRRALKBH5SUCNR1 | |
| SCHEMBL10988936 | 0.97 | LMNA (0.44) | LMNALDHASRRALKBH5SUCNR1 | |
| SCHEMBL1134677 | 0.93 | LMNA (0.41) | LMNALDHASRRALKBH5SUCNR1 | |
| SCHEMBL18160753 | 0.93 | LMNA (0.41) | LMNALDHASRRALKBH5SUCNR1 | |
| SCHEMBL6343644 | 0.93 | LMNA (0.41) | LMNALDHASRRALKBH5SUCNR1 | |
| Water SCHEMBL4057424 | 0.93 | LMNA (0.41) | LMNALDHASRRALKBH5SUCNR1 | |
| SCHEMBL1684976 | 0.93 | LMNA (0.41) | LMNALDHASRRALKBH5SUCNR1 | |
| SCHEMBL8186348 | 0.88 | LMNA (0.44) | LMNALDHASRRALKBH5SUCNR1 | |
| SCHEMBL10608338 | 0.87 | CAMK2A (0.36) | LMNALDHASRRALKBH5SUCNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9012684-B2 | Aminocarboxylate powders with improved purity and flowability properties | DOW GLOBAL TECHNOLOGIES LLC | 2015-04-21 | — | — | US | claimed |
| EP-2571846-A2 | AMINOCARBOXYLATE POWDERS WITH IMPROVED PURITY AND FLOW ABILITY PROPERTIES | Dow Global Technologies LLC (US) | 2013-03-27 | — | — | EP | claimed |
| US-20110288332-A1 | AMINOCARBOXYLATE POWDERS WITH IMPROVED PURITY AND FLOWABILITY PROPERTIES | DOW GLOBAL TECHNOLOGIES LLC | 2011-11-24 | — | — | US | claimed |
| WO-2011146582-A2 | AMINOCARBOXYLATE POWDERS WITH IMPROVED PURITY AND FLOW ABILITY PROPERTIES | DOW GLOBAL TECHNOLOGIES LLC. (US) | 2011-11-24 | — | — | WO | claimed |
| EP-3848349-B1 | A PROCESS FOR THE PREPARATION OF SALTS OF N,N'-DISUBSTITUTED ETHYLENEDIAMINE-N,N'-DIACETIC ACID DERIVATIVES AND THEIR USE | PRZED PRODUKCYJNO CONSULTINGOWE ADOB SP Z O O (PL) | 2023-03-15 | — | — | EP | disclosed |
| EP-3848349-A1 | A PROCESS FOR THE PREPARATION OF SALTS OF N,N'-DISUBSTITUTED ETHYLENEDIAMINE-N,N'-DIACETIC ACID DERIVATIVES AND THEIR USE | Przedsiebiorstwo Produkcyjno-Consultingowe ADOB Sp. z o.o. Sp. jawna (PL) | 2021-07-14 | — | — | EP | disclosed |
| EP-1861486-B1 | A PROCESS OF PREPARING JAMBU EXTRACT, USE OF SAID EXTRACT, COSMETIC COMPOSITIONS COMPRISING THEREOF AND COSMETIC PRODUCTS COMPRISING SAID COSMETIC COMPOSITIONS | NATURA COSMETICOS SA (BR) | 2017-05-17 | — | — | EP | disclosed |
| US-9056089-B2 | Process of preparing jambu extract, use of said extract, cosmetic compositions comprising thereof and cosmetic products comprising said cosmetic compositions | NATURA COSMETICOS S.A. (BR) | 2015-06-16 | — | — | US | disclosed |
| EP-2743254-A1 | Method for preparing an aminocarboxylate chelant containing low level of nitrilotriacetic acid | Dow Global Technologies LLC (US) | 2014-06-18 | — | — | EP | disclosed |
| US-20080171003-A1 | free from chlorophyll and its derivatives; by selective basic hydrolysis of chlorophyll; high yield, simplification; extracts of spilanthol | NATURA COSMETICOS S.A. (BR) | 2008-07-17 | — | — | US | disclosed |
| US-4051234-A | BIS-GUANIDINE COMPOUND, ETHYLENEDIAMINEDIACETIC ACID OR SALT AS CHELATOR | THE PROCTER & GAMBLE COMPANY (US) | 1977-09-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080171003-A1 | free from chlorophyll and its derivatives; by selective basic hydrolysis of chlorophyll; high yield, simplification; extracts of spilanthol | TYR, HMBS, NISCH | LMNA 1505/4885LDHA 2114/4885SRR 589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.